4
Changes in Ownership
Foghorn Therapeutics Inc. Filed Acc 0001562180-24-003439
Options or other derivatives
- Chief Financial Officer acquired 275,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Humer Kristian Chief Financial Officer | 2024-04-16 | Grant or award · Stock Option (Right to buy) | +275,000 | $6.03 | $1,658,250 | 275,000 | D |
Loading xslF345X05/primarydocument.xml…